Remix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.

Biotechnology

Health Care

Therapeutics

Remix Therapeutics

Peter Smith

Dominic Reynolds

Mark Scuzzarella

Silvia Buonamici

Rob Gagnon

Matthew Schnaderbeck

Cecile Blaustein

Heather Wasserman

The Operations Team at Remix Therapeutics is responsible for overseeing and streamlining the company's clinical development, patient engagement, and program management processes. They ensure efficient project execution, resource allocation, and strategic planning to support the development of novel RNA-targeted therapies.

Operations Team

Scientific Advisory Team

Scientific and Research Team

Advisory Team

Operations Team

About

Team members

Other teams at Remix Therapeutics

Scientific Advisory Team

Scientific and Research Team

Advisory Team